BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10374839)

  • 1. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
    Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
    Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1.
    Riley J; Mandel HG; Sinha S; Judah DJ; Neal GE
    Carcinogenesis; 1997 May; 18(5):905-10. PubMed ID: 9163674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis.
    Sinha S; Webber C; Marshall CJ; Knowles MA; Proctor A; Barrass NC; Neal GE
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3673-7. PubMed ID: 3287372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
    Hulla JE; Chen ZY; Eaton DL
    Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
    McMahon G; Davis EF; Huber LJ; Kim Y; Wogan GN
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1104-8. PubMed ID: 2105496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro aflatoxin B1-induced p53 mutations.
    Chan KT; Hsieh DP; Lung ML
    Cancer Lett; 2003 Sep; 199(1):1-7. PubMed ID: 12963117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
    Paget V; Sichel F; Garon D; Lechevrel M
    Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.
    Aguilar F; Hussain SP; Cerutti P
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8586-90. PubMed ID: 8397412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions.
    Lee CC; Liu JY; Lin JK; Chu JS; Shew JY
    Cancer Lett; 1998 Mar; 125(1-2):1-7. PubMed ID: 9566688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
    Fujimoto Y; Hampton LL; Luo LD; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1992 Feb; 52(4):1044-6. PubMed ID: 1310637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes.
    Chao HK; Tsai TF; Lin CS; Su TS
    Mol Carcinog; 1999 Oct; 26(2):69-73. PubMed ID: 10506750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation related expression of glutathione-S-transferase P in rat liver cells.
    Power C; Sinha S; Webber C; Manson MM; Neal GE
    Carcinogenesis; 1987 Jun; 8(6):797-801. PubMed ID: 3111738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors.
    McMahon G; Davis E; Wogan GN
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4974-8. PubMed ID: 3110778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of activated c-H-ras oncogene in the induction and progression of immortal liver epithelial cell lines derived from normal C3H mice.
    Lee GH; Sakai R; Nagao M; Kitagawa T
    Int J Cancer; 1991 Jan; 47(1):60-5. PubMed ID: 1985880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.
    McMahon G; Hanson L; Lee JJ; Wogan GN
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9418-22. PubMed ID: 3099282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.